Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

• Egile Nagusiak: Hamdy SM (Egilea), Abdel-Naseer M (Egilea), Shehata HS (Egilea), Hassan A (Egilea), Elmazny A (Egilea), Shalaby NM (Egilea), Abokrysha NT (Egilea), Kishk NA (Egilea), Nada MAF (Egilea), Ahmed SM (Egilea), Hegazy MI (Egilea), Mekkawy D (Egilea), Mourad HS (Egilea), Abdelalim A (Egilea), Berger T (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2020-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Sherif M Hamdy,1 Maged Abdel-Naseer,1 Hatem S Shehata,1 Amr Hassan,1 Alaa Elmazny,1 Nevin M Shalaby,1 Noha T Abokrysha,1 Nirmeen A Kishk,1 Mona AF Nada,1 Sandra M Ahmed,1 Mohamed I Hegazy,1 Doaa Mekkawy,1 Husam S Mourad,1 Ahmed Abdelalim,1 Thomas Berger2 1Neurology Department, Faculty of Medicine, C...